Clinical Trial Update: Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing safety and effectiveness of Pegasys (pegylated interferon alfa-2a) and Copegus (ribavirin) in liver transplant recipients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Mayo Clinic | Conditions: Liver Transplant, Hepatitis C | Phase 4 | Status: COMPLETED